Investigational Site Number 840005

New York, New York 10021

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Plasma Cell Myeloma

Studies at this site

• SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients — Completed
• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed